dronabinol has been researched along with CB-13 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, YX; Lessard, E; Luo, X; Payza, K; Pourashraf, M; Salois, D; Srivastava, S; St-Onge, S; Tomaszewski, MJ; Walpole, C; Yu, XH | 1 |
| Limebeer, CL; Mechoulam, R; Parker, LA; Rock, EM | 1 |
2 other study(ies) available for dronabinol and CB-13
| Article | Year |
|---|---|
γ-Carbolines: a novel class of cannabinoid agonists with high aqueous solubility and restricted CNS penetration.
Topics: Analgesics; Animals; Brain; Cannabinoids; Carbolines; Cell Line; Drug Stability; Humans; Molecular Structure; Pain; Rats; Solubility | 2012 |
The anti-nausea effects of CB1 agonists are mediated by an action at the visceral insular cortex.
Topics: Animals; Antiemetics; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cerebral Cortex; Dronabinol; Lithium Chloride; Male; Naphthalenes; Nausea; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1 | 2012 |